These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors. Placzek AN; Grassi F; Papke T; Meyer EM; Papke RL Mol Pharmacol; 2004 Jul; 66(1):169-77. PubMed ID: 15213309 [TBL] [Abstract][Full Text] [Related]
3. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. Khiroug SS; Harkness PC; Lamb PW; Sudweeks SN; Khiroug L; Millar NS; Yakel JL J Physiol; 2002 Apr; 540(Pt 2):425-34. PubMed ID: 11956333 [TBL] [Abstract][Full Text] [Related]
4. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation. Fucile S; Palma E; Eusebi F; Miledi R Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381 [TBL] [Abstract][Full Text] [Related]
5. Binding-gating coupling in a nondesensitizing alpha7 nicotinic receptor A single channel pharmacological study. Bernal JA; Mulet J; Castillo M; Criado M; Sala S; Sala F Biochim Biophys Acta; 2009 Feb; 1788(2):410-6. PubMed ID: 19063861 [TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107. Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915 [TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004 [TBL] [Abstract][Full Text] [Related]
9. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties. Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615 [TBL] [Abstract][Full Text] [Related]
10. Single amino acid residue in the extracellular portion of transmembrane segment 2 in the nicotinic alpha7 acetylcholine receptor modulates sensitivity to ketamine. Ho KK; Flood P Anesthesiology; 2004 Mar; 100(3):657-62. PubMed ID: 15108982 [TBL] [Abstract][Full Text] [Related]
11. Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance. Pałczyńska MM; Jindrichova M; Gibb AJ; Millar NS Mol Pharmacol; 2012 Nov; 82(5):910-7. PubMed ID: 22874415 [TBL] [Abstract][Full Text] [Related]
12. α7β2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfaces. Murray TA; Bertrand D; Papke RL; George AA; Pantoja R; Srinivasan R; Liu Q; Wu J; Whiteaker P; Lester HA; Lukas RJ Mol Pharmacol; 2012 Feb; 81(2):175-88. PubMed ID: 22039094 [TBL] [Abstract][Full Text] [Related]
13. Aromatic residues at position 55 of rat alpha7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization. Gay EA; Giniatullin R; Skorinkin A; Yakel JL J Physiol; 2008 Feb; 586(4):1105-15. PubMed ID: 18096596 [TBL] [Abstract][Full Text] [Related]
14. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station. Malysz J; Grønlien JH; Timmermann DB; Håkerud M; Thorin-Hagene K; Ween H; Trumbull JD; Xiong Y; Briggs CA; Ahring PK; Dyhring T; Gopalakrishnan M Assay Drug Dev Technol; 2009 Aug; 7(4):374-90. PubMed ID: 19689206 [TBL] [Abstract][Full Text] [Related]
16. Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. Grassi F; Palma E; Tonini R; Amici M; Ballivet M; Eusebi F J Physiol; 2003 Feb; 547(Pt 1):147-57. PubMed ID: 12562926 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. Papke RL; Porter Papke JK Br J Pharmacol; 2002 Sep; 137(1):49-61. PubMed ID: 12183330 [TBL] [Abstract][Full Text] [Related]
18. Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures. Williams DK; Peng C; Kimbrell MR; Papke RL Mol Pharmacol; 2012 Oct; 82(4):746-59. PubMed ID: 22828799 [TBL] [Abstract][Full Text] [Related]
19. Desensitization characteristics of the human alpha7nAChR/5HT3A chimera receptor. Dinklo T; Lesage AS; Grantham CG J Mol Neurosci; 2006; 30(1-2):109-10. PubMed ID: 17192651 [TBL] [Abstract][Full Text] [Related]
20. Kinetic properties and open probability of α7 nicotinic acetylcholine receptors. Pesti K; Szabo AK; Mike A; Vizi ES Neuropharmacology; 2014 Jun; 81():101-15. PubMed ID: 24486379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]